USE OF A RADIOACTIVELY LABELLED MOLECULE SPECIFICALLY BINDING TO ED-B FIBRONECTIN IN A METHOD OF HODGKIN LYMPHOMA

摘要

The invention relates to the use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of treatment for patients with Hodgkin lymphoma, in particular primary refractory Hodgkin lymphoma or recurrent Hodgkin lymphoma after chemotherapy, and for Hodgkin lymphoma patients scheduled for primary combined-modality therapy.